OXCT1, an enzyme that catalyzes the reversible transfer of CoA from succinyl-CoA to acetoacetate in mitochondrial membranes [50], is considered a therapeutic target in cancer by virtue of its regulation of ketone bodies [51]. Here, OXCT1 is linked to cancer.